United States · FDA National Drug Code directory
POTASSIUM CHLORIDE EXTENDED RELEASE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70010-021_f33d5a34-e5e7-a85f-e053-2995a90a6db3
- Product NDC
- 70010-021
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- POTASSIUM CHLORIDE
- Labeler
- Granules Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201022
- Source listing expiry
- 20261231
Source-listed ingredients
- POTASSIUM CHLORIDE — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-021-01) · 70010-021-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-021-05) · 70010-021-05
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-021-10) · 70010-021-10
- 3 BLISTER PACK in 1 CARTON (70010-021-61) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 70010-021-61
- 10 BLISTER PACK in 1 CARTON (70010-021-62) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 70010-021-62
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →